Several studies conducted on patients with NF-2, including those suffering from skin cancers, vestibular schwannomas, and meningiomas, have posited that the loss of heterozygosity, including allelic loss of NF-2, may contribute to neoplastic developments [55,56]. This evidence concerns the gene NF2 and skin cancer.